Search Non-Antibody Products
|
|
|
|
|
Non-antibody Products (Kits, Proteins, Microbial Antigens, Tissues, Services, etc.) - Page 2 of 5,777
| Name |
Description |
Size |
Catalog # |
Supplier |
|
| AS 605240 |
Minimum Purity: > 98%. Potent and selective inhibitor of PI 3-kinase gamma (PI3Kgamma) (IC50 = 8 nM). Displays 30-fold selectivity over PI3Kdelta and PI3Kbeta and 7.5-fold selectivity over PI3Kalpha. Suppresses the progression of joint inflammatio... |
10mg |
3578 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 605240 |
Minimum Purity: > 98%. Potent and selective inhibitor of PI 3-kinase gamma (PI3Kgamma) (IC50 = 8 nM). Displays 30-fold selectivity over PI3Kdelta and PI3Kbeta and 7.5-fold selectivity over PI3Kalpha. Suppresses the progression of joint inflammatio... |
50mg |
3578 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 605240 |
PI 3-Kinase Inhibitor |
10 mg |
3578/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 605240 |
PI 3-Kinase Inhibitor |
50 mg |
3578/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 740003 |
Minimum Purity: > 98%. Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). Displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 &m... |
10mg |
3701 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 740003 |
Minimum Purity: > 98%. Potent, selective and competitive P2X7 receptor antagonist (IC50 values are 18 and 40 nM for rat and human receptors respectively). Displays selectivity over a variety of P2X and P2Y receptors up to a concentration of 100 &m... |
50mg |
3701 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 740003 |
P2X Receptor Antagonist |
10 mg |
3701/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 740003 |
P2X Receptor Antagonist |
50 mg |
3701/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 769662 |
AMP-activated protein kinase activator |
10mg |
Asc-335-10mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| A 769662 |
AMP-activated protein kinase activator |
50mg |
Asc-335-50mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| A 769662 |
Minimum Purity: > 98%. Potent, reversible AMP-activated protein kinase (AMPK) activator (EC50 = 0.8 µM) that displays selectivity towards beta1 subunit-containing heterotrimers. Inhibits fatty acid synthesis (IC50 = 3.2 µM) and decreas... |
10mg |
3336 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 769662 |
Minimum Purity: > 98%. Potent, reversible AMP-activated protein kinase (AMPK) activator (EC50 = 0.8 µM) that displays selectivity towards beta1 subunit-containing heterotrimers. Inhibits fatty acid synthesis (IC50 = 3.2 µM) and decreas... |
50mg |
3336 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 769662 |
AMPK Activator |
10 mg |
3336/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 769662 |
AMPK Activator |
50 mg |
3336/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 803467 |
Selective NaV1.8 channel blocker |
10mg |
Asc-282-10mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| A 803467 |
Selective NaV1.8 channel blocker |
50mg |
Asc-282-50mg |
 ASCENT SCIENTIFIC LTD. |
More Info
|
| A 803467 |
Minimum Purity: > 98%. Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against TRPV1, P2X2/3, CaV2.2 and... |
10mg |
2976 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 803467 |
Minimum Purity: > 98%. Selective blocker of NaV1.8 channels (IC50 values are 8, 2450, 6740, 7340 and 7380 nM for hNaV1.8, hNaV1.3, hNaV1.7, hNaV1.5 and hNaV1.2 channels respectively). Shows no significant activity against TRPV1, P2X2/3, CaV2.2 and... |
50mg |
2976 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 803467 |
n/a |
10 mg |
2976/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 803467 |
n/a |
50 mg |
2976/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 80426 |
Adrenergic alpha-2 Receptor Antagonist |
10 mg |
2341/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 80426 |
Adrenergic alpha-2 Receptor Antagonist |
50 mg |
2341/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
Minimum Purity: > 98%. Selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TG... |
10mg |
2939 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 83-01 |
Minimum Purity: > 98%. Selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TG... |
50mg |
2939 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 83-01 |
A selective inhibitor of TGF-beta type I receptor ALK5 kinase, type I activin/nodal receptor ALK4 and type I nodal receptor ALK7 (IC50 values are 12, 45 and 7.5 nM respectively). Blocks phosphorylation of Smad2 and inhibits TGF-beta-induced epithe... |
1 mg |
1725-1 |
 BIOVISION, INC. |
More Info
|
| A 83-01 |
TGF-beta Receptor Inhibitor |
10 mg |
2939/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 83-01 |
TGF-beta Receptor Inhibitor |
50 mg |
2939/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 839977 |
Minimum Purity: > 98%. Potent P2X7 antagonist; blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20, 42 and 150 nM respectively). Displays antinociceptive effects in rat and mice models of infla... |
50mg |
4232 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 839977 |
Minimum Purity: > 98%. Potent P2X7 antagonist; blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20, 42 and 150 nM respectively). Displays antinociceptive effects in rat and mice models of infla... |
10mg |
4232 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 839977 |
P2X Receptor Antagonist |
10 mg |
4232/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 839977 |
P2X Receptor Antagonist |
50 mg |
4232/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 841720 |
Minimum Purity: > 98%. Potent, non-competitive mGlu1 receptor antagonist that displays 34-fold selectivity over mGlu5 (IC50 values are 10 and 342 nM respectively). Displays no significant activity at a range of other GPCRs, ion channels and transp... |
10mg |
3060 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 841720 |
Minimum Purity: > 98%. Potent, non-competitive mGlu1 receptor antagonist that displays 34-fold selectivity over mGlu5 (IC50 values are 10 and 342 nM respectively). Displays no significant activity at a range of other GPCRs, ion channels and transp... |
50mg |
3060 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 841720 |
Group I mGluR Antagonist |
10 mg |
3060/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 841720 |
Group I mGluR Antagonist |
50 mg |
3060/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 887826 |
n/a |
10 mg |
4249/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 887826 |
n/a |
50 mg |
4249/50 |
 R&D SYSTEMS, INC. |
More Info
|
| 92.1.7 |
n/a |
n/a |
n/a |
VIRCELL S.L. |
More Info
|
| A 922500 |
Minimum Purity: > 98%. Diacylglycerol acyltransferase 1 (DGAT-1) inhibitor (IC50 values are 7 and 24 nM at human and mouse DGAT-1 respectively) that is devoid of activity at DGAT-2, ACAT1 or ACAT2. Induces significant weight loss without altering ... |
10mg |
3587 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 922500 |
Acyltransferase Inhibitor |
10 mg |
3587/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 987306 |
Minimum Purity: > 98%. Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors. Blocks zymosan-i... |
10mg |
3640 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 987306 |
Minimum Purity: > 98%. Potent histamine H4 receptor antagonist (pKi values are 8.24 and 8.47 in human and rat H4 receptors respectively). Displays 162-fold, 620-fold, and > 1600-fold selectivity over human H3, H1 and H2 receptors. Blocks zymosan-i... |
50mg |
3640 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 987306 |
Histamine H4 Receptor Antagonist |
10 mg |
3640/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 987306 |
Histamine H4 Receptor Antagonist |
50 mg |
3640/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A2.01 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| A3.01 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| A549 |
n/a |
n/a |
n/a |
VIRCELL S.L. |
More Info
|
| A23187 |
Purity: >98%. Effective Concentration: 1-10 μM. A23187, Calcimycin, Ca2+ Ionophore A23187, A23187 is a mobile-carrier Ca2+ ionophore (allows Ca2+ ions to cross cell membranes) originally isolated as an antibiotic from Streptomyces chartreusen... |
1 mg |
A-600 |
 ALOMONE LABS |
More Info
|
| A23187 |
Purity: >98%. Effective Concentration: 1-10 μM. A23187, Calcimycin, Ca2+ Ionophore A23187, A23187 is a mobile-carrier Ca2+ ionophore (allows Ca2+ ions to cross cell membranes) originally isolated as an antibiotic from Streptomyces chartreusen... |
5 mg |
A-600 |
 ALOMONE LABS |
More Info
|
| A23187 |
Purity: >98%. Effective Concentration: 1-10 μM. A23187, Calcimycin, Ca2+ Ionophore A23187, A23187 is a mobile-carrier Ca2+ ionophore (allows Ca2+ ions to cross cell membranes) originally isolated as an antibiotic from Streptomyces chartreusen... |
10 mg |
A-600 |
 ALOMONE LABS |
More Info
|
Search Non-Antibody Products
|